Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer
Version 2 2024-05-31, 04:08Version 2 2024-05-31, 04:08
Version 1 2023-11-02, 05:12Version 1 2023-11-02, 05:12
journal contribution
posted on 2024-05-31, 04:08authored byHM Prince, J Gardyn, MJ Millward, D Rischin, P Francis, Priscilla GatesPriscilla Gates, P Chapple, M Quinn, S Juneja, M Wolf, EH Januszewicz, G Richardson, J Scarlett, P Briggs, M Brettell, GC Toner
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer